{"id":59456,"date":"2024-02-28T05:59:00","date_gmt":"2024-02-28T05:59:00","guid":{"rendered":"https:\/\/medsname.com\/nimodip\/"},"modified":"2026-05-01T10:49:15","modified_gmt":"2026-05-01T10:49:15","slug":"nimodip","status":"publish","type":"product","link":"https:\/\/medsbase.com\/ro\/product\/nimodip\/","title":{"rendered":"Nimodip"},"content":{"rendered":"<p><!-- medsbase-tldr-answer --><\/p>\n<div style=\"background:#fff8e1;border-left:4px solid #f5a623;padding:18px 22px;margin:0 0 24px 0;border-radius:4px;\">\n<h3 class=\"wp-block-heading\" style=\"margin:0 0 8px 0;font-size:16px;font-weight:700;\">\u26a1 R\u0103spuns rapid \u2014 Ce este Nimodip?<\/h3>\n<p style=\"margin:0;\"><strong>Nimodip<\/strong> este un <strong>nimodipine<\/strong> (30 mg) tablet\u0103 \u2014 un <strong>blocator selectiv cerebral al canalelor de calciu dihidropiridinic<\/strong> utilizat specific pentru prevenirea \u0219i reducerea severit\u0103\u021bii <strong>vasospasmului cerebral<\/strong> \u0219i <strong>ischemiei cerebrale \u00eent\u00e2rziate (ICI)<\/strong> dup\u0103 <strong>hemoragia subarahnoid\u0103 aneurismal\u0103 (HSA)<\/strong>. Dozare: <strong>60 mg la fiecare 4 ore (360 mg\/zi) timp de 21 de zile consecutive<\/strong>, \u00eenceput\u0103 \u00een termen de 96 de ore de la hemoragie. Nimodipina dilateaz\u0103 preferen\u021bial arterele cerebrale fa\u021b\u0103 de cele periferice, reduc\u00e2nd inciden\u021ba deficitelor neurologice legate de vasospasm f\u0103r\u0103 a provoca hipotensiune sistemic\u0103 semnificativ\u0103 la dozele standard. Efecte secundare frecvente: hipotensiune, cefalee, grea\u021b\u0103, ro\u0219ea\u021b\u0103.<\/p>\n<\/div>\n<div class=\"medsbase-trust-strip\" style=\"background:#f4f8fb;border:1px solid #d8e3eb;padding:12px 16px;margin:16px 0;border-radius:4px;font-size:14px;\">\n<strong>Ce beneficii ofer\u0103 MedsBase:<\/strong> Produc\u0103tor certificat WHO-GMP \u00b7 Ambalaj discret \u00b7 Livrare la nivel mondial \u00b7 Peste 1.400 de recenzii verificate <a href=\"https:\/\/medsbase.com\/ro\/reviews\/\">ale clien\u021bilor<\/a>\n<\/div>\n<p class=\"medsbase-reship-line\" style=\"font-size:14px;color:#444;margin:8px 0 18px;\">\ud83d\udce6 Fiecare comand\u0103 este acoperit\u0103 de politica noastr\u0103 de <a href=\"https:\/\/medsbase.com\/ro\/medsbase-re-shipment-assurance-policy\/\"><strong>Politica noastr\u0103 de Reexpediere Garantat\u0103<\/strong><\/a> \u2014 dac\u0103 coletul dumneavoastr\u0103 nu sose\u0219te \u00een 20 de zile lucr\u0103toare, \u00eel relivr\u0103m.<\/p>\n<h3>De ce s\u0103 comanzi de la MedsBase<\/h3>\n<p>Medicamentele noastre generice sunt procurate de la produc\u0103tori certifica\u021bi WHO-GMP \u0219i expediate la nivel mondial \u00een ambalaje discrete \u0219i simple \u2014 f\u0103r\u0103 denumirea medicamentului pe exteriorul coletului. Pl\u0103\u021bile cu cardul sunt procesate printr-un procesor reglementat (descrierile de pe extrasul de cont includ un procesor de pl\u0103\u021bi cu card reglementat \u2014 niciodat\u0103 \u201cMedsBase\u201d sau numele vreunui medicament). Accept\u0103m \u0219i criptomonede \u0219i transferuri bancare SEPA. Fiecare comand\u0103 este sus\u021binut\u0103 de Politica noastr\u0103 de Asigurare pentru Relivrare.<\/p>\n<h2 class=\"wp-block-heading\">Ce este Nimodip?<\/h2>\n<p>Nimodip este o tablet\u0103 oral\u0103 care con\u021bine <strong>nimodipin\u0103 30 mg<\/strong>. Nimodipina este un <strong>blocator selectiv cerebral al canalelor de calciu dihidropiridinic<\/strong> \u2014 spre deosebire de alte BCC (amlodipina, nifedipina), dilateaz\u0103 preferen\u021bial arterele cerebrale cu un efect minimal asupra tensiunii arteriale periferice.<\/p>\n<p>Nimodipina este <strong>singurul blocant al canalelor de calciu cu indica\u021bie neurologic\u0103<\/strong>: prevenirea deficitelor neurologice ischemice (vasospasm) dup\u0103 hemoragia subarahnoid\u0103 aneurismal\u0103 <strong>hemoragie subarahnoidian\u0103 (HSA)<\/strong>. Studiul emblematic BIDA (1983) a demonstrat o reducere de ~40% a infarctului cerebral \u0219i \u00eembun\u0103t\u0103\u021birea rezultatelor neurologice cu protocolul oral standard de 21 de zile. Nimodip este fabricat \u00eentr-o unitate certificat\u0103 WHO-GMP \u0219i este bioechivalent cu marca original\u0103 <strong>Nimotop<\/strong> (Bayer).<\/p>\n<h2 class=\"wp-block-heading\">How Does Nimodip (Nimodipine) Work?<\/h2>\n<p>Nimodipine blocheaz\u0103 <strong>canalele de calciu dependente de voltaj de tip L<\/strong>, dar spre deosebire de alte blocante ale canalelor de calciu (amlodipin\u0103, nifedipin\u0103), acesta are <strong>afinitate preferen\u021bial\u0103 pentru mu\u0219chiul neted vascular cerebral<\/strong>. Aceast\u0103 selectivitate cerebral\u0103 \u00eenseamn\u0103 c\u0103 dilat\u0103 arterele cerebrale mai mult dec\u00e2t cele periferice, f\u0103c\u00e2nd-o unic potrivit\u0103 pentru prevenirea vasospasmului dup\u0103 hemoragia subarahnoid\u0103.<\/p>\n<p>Pe l\u00e2ng\u0103 vasodilata\u021bie, nimodipina poate avea <strong>efecte neuroprotectoare<\/strong> \u2014 reduce intrarea de calciu \u00een neuroni \u00een timpul ischemiei, ceea ce atenueaz\u0103 moartea celular\u0103 excitotoxic\u0103. Studiile clinice (renumitul British Aneurysm Nimodipine Trial) au demonstrat o reducere semnificativ\u0103 a rezultatelor nefavorabile, chiar dac\u0103 ratele de vasospasm angiografic nu au fost dramatic diferite \u2014 suger\u00e2nd c\u0103 beneficiul este par\u021bial neuroprotector.<\/p>\n<h2 class=\"wp-block-heading\">Indica\u021bii<\/h2>\n<ul>\n<li><strong>Prevenirea vasospasmului cerebral<\/strong> \u0219i a ischemiei cerebrale \u00eent\u00e2rziate dup\u0103 hemoragia subarahnoid\u0103 aneurismal\u0103 \u2014 <strong>singura indica\u021bie aprobat\u0103<\/strong><\/li>\n<li><strong>Utiliz\u0103ri off-label:<\/strong> profilaxia migrenei, demen\u021ba vascular\u0103 (dovezi limitate), hemoragia subarahnoid\u0103 traumatic\u0103<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Doza \u2014 Protocolul de 21 de zile<\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:0 0 24px 0;\">\n<thead>\n<tr style=\"background:#2c7cb0;color:#fff;\">\n<th style=\"padding:10px 14px;\">Parametru<\/th>\n<th style=\"padding:10px 14px;\">Protocol standard<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding:10px 14px;\">Doza<\/td>\n<td style=\"padding:10px 14px;\">60 mg (dou\u0103 comprimate de 30 mg)<\/td>\n<\/tr>\n<tr style=\"background:#f9f9f9;\">\n<td style=\"padding:10px 14px;\">Frecven\u021b\u0103<\/td>\n<td style=\"padding:10px 14px;\">La fiecare 4 ore<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:10px 14px;\">Doza zilnic\u0103 total\u0103<\/td>\n<td style=\"padding:10px 14px;\">360 mg\/zi<\/td>\n<\/tr>\n<tr style=\"background:#f9f9f9;\">\n<td style=\"padding:10px 14px;\">Durat\u0103<\/td>\n<td style=\"padding:10px 14px;\">21 de zile consecutive<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:10px 14px;\">Inicia\u021bi<\/td>\n<td style=\"padding:10px 14px;\">\u00cen termen de 96 de ore de la hemoragie<\/td>\n<\/tr>\n<tr style=\"background:#f9f9f9;\">\n<td style=\"padding:10px 14px;\">Insuficien\u021b\u0103 hepatic\u0103<\/td>\n<td style=\"padding:10px 14px;\">30 mg la fiecare 4 ore (doz\u0103 redus\u0103 la jum\u0103tate)<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><strong>Critic:<\/strong> Comprimatele de Nimodipin\u0103 trebuie s\u0103 fie <strong>\u00eenghi\u021bite \u00eentregi<\/strong>, nu zdrobite. Pentru pacien\u021bii care nu pot \u00eenghi\u021bi, con\u021binutul poate fi extras cu seringa \u0219i administrat printr-un sond nazogastric \u2014 dar <strong>nu injecta\u021bi niciodat\u0103 solu\u021bia oral\u0103 intravenos<\/strong> (s-au \u00eenregistrat cazuri fatale din cauza administr\u0103rii accidentale IV a nimodipinei orale). Lua\u021bi cu cel pu\u021bin 1 or\u0103 \u00eenainte sau 2 ore dup\u0103 mese pentru absorb\u021bie optim\u0103.<\/p>\n<h2 class=\"wp-block-heading\">Efecte Secundare<\/h2>\n<p><strong>Frecvente:<\/strong> hipotensiune (dependent\u0103 de doz\u0103, de obicei u\u0219oar\u0103), cefalee, grea\u021b\u0103, flushing, edem periferic.<\/p>\n<p><strong>Mai pu\u021bin frecvente:<\/strong> ame\u021beli, tahicardie, erup\u021bii cutanate, tulbur\u0103ri gastrointestinale, bradicardie.<\/p>\n<p><strong>Grave:<\/strong> hipotensiune sever\u0103 (\u00een special la pacien\u021bii cu tensiune arterial\u0103 sc\u0103zut\u0103 preexistent\u0103 sau care iau al\u021bi antihipertensivi), ileus (la pacien\u021bii critici cu hemoragie subarahnoid\u0103), hepatotoxicitate (rar\u0103 \u2014 transaminaze crescute).<\/p>\n<h2 class=\"wp-block-heading\">Avertismente \u0219i precau\u021bii<\/h2>\n<ul>\n<li><strong>Hipotensiune.<\/strong> Nimodipina poate provoca sc\u0103deri semnificative ale tensiunii arteriale, \u00een special la pacien\u021bii cu hemoragie subarahnoid\u0103 hipovolemici sau cei care iau al\u021bi antihipertensivi. Monitoriza\u021bi TA la fiecare 1\u20132 ore \u00een primele 48 de ore. Reduce\u021bi doza la 30 mg la fiecare 4 ore (fa\u021b\u0103 de 2 ore) dac\u0103 tensiunea sistolic\u0103 scade sub 90 mmHg.<\/li>\n<li><strong>Afectare hepatic\u0103.<\/strong> Nimodipina sufer\u0103 un metabolism hepatic de prim trecere extensiv. \u00cen ciroz\u0103, biodisponibilitatea cre\u0219te semnificativ \u2014 \u00eenjum\u0103t\u0103\u021bi\u021bi doza \u0219i monitoriza\u021bi pentru hipotensiune \u0219i bradicardie.<\/li>\n<li><strong>Edem cerebral \/ cre\u0219tere a presiunii intracraniene.<\/strong> Folosi\u021bi cu precau\u021bie la pacien\u021bii cu edem cerebral sau presiune intracranian\u0103 sever crescut\u0103.<\/li>\n<li><strong>Suc de grapefruit.<\/strong> Inhib\u0103 metabolismul CYP3A4 al nimodipinei, dubl\u00e2nd nivelurile plasmatice. Evita\u021bi produsele din grapefruit \u00een timpul protocolului de 21 de zile.<\/li>\n<li><strong>Epilepsie.<\/strong> Utiliza\u021bi nimodipina cu precau\u021bie la pacien\u021bii cu epilepsie \u2014 de\u0219i nu este epileptogen\u0103, crizele sunt o complica\u021bie frecvent\u0103 a hemoragiei subarahnoidale (HSA), iar interac\u021biunile medicamentoase cu anticonvulsivantele (\u00een special inductorii enzimatici precum fenitoina \u0219i carbamazepina) sunt semnificative din punct de vedere clinic.<\/li>\n<li><strong>Categorie de risc \u00een sarcin\u0103: C.<\/strong> Teratogen la animale la doze mari. Utiliza\u021bi numai dac\u0103 beneficiul dep\u0103\u0219e\u0219te riscul.<\/li>\n<li><strong>Al\u0103ptare.<\/strong> Nimodipina este excretat\u0103 \u00een laptele matern. Semnifica\u021bia clinic\u0103 este incert\u0103 \u2014 utiliza\u021bi cu precau\u021bie.<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Contraindica\u021bii \u2014 Cine NU ar trebui s\u0103 ia Nimodip<\/h2>\n<ul>\n<li>Hipersensibilitate cunoscut\u0103 la nimodipin\u0103, alte dihidropiridine sau orice excipient<\/li>\n<li>Utilizare concomitent\u0103 cu <strong>rifampicin\u0103<\/strong> (reduce nivelul de nimodipin\u0103 la valori subterapeutice prin induc\u021bia CYP3A4)<\/li>\n<li>Utilizare concomitent\u0103 cu <strong>inhibitori puternici ai CYP3A4<\/strong> (ketoconazol, itraconazol, ritonavir) f\u0103r\u0103 reducerea dozei<\/li>\n<li>Angin\u0103 instabil\u0103 sau infarct miocardic recent (\u00een ultimele 4 s\u0103pt\u0103m\u00e2ni)<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Interac\u021biuni medicamentoase<\/h2>\n<ul>\n<li><strong>Alte antihipertensive \u0219i blocante ale canalelor de calciu:<\/strong> Hipotenziune aditiv\u0103<\/li>\n<li><strong>Inhibitori ai CYP3A4<\/strong> (ketoconazol, fluconazol, antibiotice macrolide, suc de grapefruit): Cre\u0219te semnificativ nivelul de nimodipin\u0103<\/li>\n<li><strong>Inductori CYP3A4<\/strong> (rifampicin\u0103, fenitoin\u0103, carbamazepin\u0103, fenobarbital): Reduce nivelul de nimodipin\u0103, poten\u021bial la valori subterapeutice<\/li>\n<li><strong>Beta-blocante:<\/strong> Efect cronotropic negativ aditiv \u2014 monitoriza\u021bi frecven\u021ba cardiac\u0103<\/li>\n<li><strong>Medicamente nefrotoxice:<\/strong> Nimodipina poate agrava func\u021bia renal\u0103 la pacien\u021bii cu hemoragie subarahnoid\u0103 care primesc concomitent medicamente nefrotoxice<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Instruc\u021biuni de Depozitare<\/h2>\n<ul>\n<li>Se p\u0103streaz\u0103 la temperatura camerei, <strong>15\u201325\u00b0C<\/strong>. <strong>Proteja\u021bi de lumin\u0103<\/strong> \u2014 nimodipina este sensibil\u0103 la lumin\u0103.<\/li>\n<li>P\u0103stra\u021bi \u00een ambalajul original cu blistere de culoare chihlimbar p\u00e2n\u0103 la utilizare.<\/li>\n<li>Nu depozita\u021bi \u00een baie.<\/li>\n<li>P\u0103stra\u021bi la distan\u021b\u0103 de copii.<\/li>\n<li>Nu utiliza\u021bi dup\u0103 data de expirare.<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Categorii conexe pe MedsBase<\/h2>\n<ul>\n<li><a href=\"https:\/\/medsbase.com\/ro\/neurological-conditions-and-epilepsy\/\">R\u0103sfoi\u021bi toate medicamentele neurologice \u0219i antiepileptice<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/heart-and-blood-pressure\/\">R\u0103sfoi\u021bi medicamente pentru inim\u0103 \u0219i tensiune arterial\u0103<\/a><\/li>\n<\/ul>\n<h2 id=\"faqs\">\u00centreb\u0103ri frecvente<\/h2>\n<h3 class=\"wp-block-heading\">Pentru ce se utilizeaz\u0103 Nimodip?<\/h3>\n<p>Nimodip con\u021bine <strong>nimodipin\u0103 30 mg<\/strong> \u0219i este utilizat pentru a preveni <strong>vasospasmului cerebral<\/strong> \u0219i <strong>ischemie cerebral\u0103 \u00eent\u00e2rziat\u0103<\/strong> \u00een urma hemoragiei subarahnoidale aneurismale (aSAH). Este singurul medicament dovedit c\u0103 \u00eembun\u0103t\u0103\u021be\u0219te rezultatele neurologice dup\u0103 SAH.<\/p>\n<h3 class=\"wp-block-heading\">De ce se administreaz\u0103 nimodipina la fiecare 4 ore \u0219i nu de dou\u0103 ori pe zi?<\/h3>\n<p>Nimodipina are un timp de \u00eenjum\u0103t\u0103\u021bire scurt (<strong>1\u20132 ore<\/strong> administrat\u0103 oral). Dozarea la fiecare 4 ore asigur\u0103 niveluri terapeutice continue pe parcursul perioadei critice de vasospasm de 21 de zile (zilele 3\u201314 prezint\u0103 cel mai mare risc). Omiterile de doze creeaz\u0103 lacune \u00een protec\u021bie.<\/p>\n<h3 class=\"wp-block-heading\">Nimodipina este acela\u0219i lucru cu nifedipina sau amlodipina?<\/h3>\n<p>Toate trei sunt blocante ale canalelor de calciu dihidropiridinice, dar nimodipina este <strong>selectiv\u0103 cerebral \u00een mod unic<\/strong>. Nifedipina \u0219i amlodipina vizeaz\u0103 \u00een principal arterele periferice \u0219i coronariene \u0219i sunt utilizate pentru hipertensiune\/angin\u0103. Acestea sunt <strong>nu interschimbabile<\/strong> \u2014 doar nimodipina are dovezi pentru rezultatele SAH.<\/p>\n<h3 class=\"wp-block-heading\">De ce nu trebuie administrat\u0103 niciodat\u0103 nimodipina intravenos?<\/h3>\n<p>Formul\u0103rile orale de nimodipin\u0103 con\u021bin excipien\u021bi nepotrivi\u021bi pentru injec\u021bie intravenoas\u0103. Administrarea inadvertent\u0103 IV a provocat <strong>colaps cardiovascular \u0219i deces<\/strong>. C\u00e2nd dozarea oral\u0103 este imposibil\u0103 (pacien\u021bi incon\u0219tien\u021bi), nimodipina trebuie administrat\u0103 prin sond\u0103 nazogastric\u0103, nu injectat\u0103.<\/p>\n<h3 class=\"wp-block-heading\">Previne nimodipina cu adev\u0103rat vasospasmul?<\/h3>\n<p>Interesant, nimodipina <strong>nu reduce semnificativ vasospasmul angiografic<\/strong>. Beneficiul s\u0103u pare a fi \u00een primul r\u00e2nd <strong>neuroprotector<\/strong> \u2014 reduc\u00e2nd daunele neuronale ischemice cauzate de vasospasm, mai degrab\u0103 dec\u00e2t prevenind spasmul \u00een sine. Rezultatul clinic este un num\u0103r mai mic de pacien\u021bi cu deficite neurologice permanente.<\/p>\n<h3 class=\"wp-block-heading\">Pot lua nimodipin\u0103 cu suc de grapefruit?<\/h3>\n<p><strong>Nu.<\/strong> Sucul de grapefruit inhib\u0103 CYP3A4, cresc\u00e2nd semnificativ nivelurile de nimodipin\u0103 \u0219i riscul de hipotensiune. Evita\u021bi grapefruitul pe tot parcursul tratamentului.<\/p>\n<h3 class=\"wp-block-heading\">Ce se \u00eent\u00e2mpl\u0103 dac\u0103 uit o doz\u0103?<\/h3>\n<p>Lua\u021bi doza uitat\u0103 c\u00e2t mai cur\u00e2nd posibil. Dac\u0103 este aproape timpul pentru urm\u0103toarea doz\u0103, omite\u021bi cea ratat\u0103 \u0219i continua\u021bi conform programului. Av\u00e2nd \u00een vedere timpul de \u00eenjum\u0103t\u0103\u021bire scurt, orice \u00eent\u00e2rziere reduce protec\u021bia \u00een perioada critic\u0103 a vasospasmului.<\/p>\n<h3 class=\"wp-block-heading\">Se folose\u0219te nimodipina pentru migrene?<\/h3>\n<p>Nimodipina a fost studiat\u0103 pentru <strong>profilaxia migrenei<\/strong> cu rezultate mixte. Unii pacien\u021bi beneficiaz\u0103, dar nu este un tratament preventiv de prim\u0103 linie pentru migrene \u2014 propranololul, topiramatul \u0219i valproatul au dovezi mai solide. Se folose\u0219te off-label c\u00e2nd alte op\u021biuni au e\u0219uat sau sunt contraindicate.<\/p>\n<h3 class=\"wp-block-heading\">Poate nimodipina s\u0103 scad\u0103 prea mult tensiunea arterial\u0103?<\/h3>\n<p>Da \u2014 hipotensiunea este principala preocupare clinic\u0103. La pacien\u021bii cu hemoragie subarahnoid\u0103, men\u021binerea unei presiuni de perfuzie cerebral\u0103 adecvate este critic\u0103. Tensiunea arterial\u0103 trebuie monitorizat\u0103 regulat, iar doza poate fi redus\u0103 la jum\u0103tate (30 mg la fiecare 4 ore) la pacien\u021bii cu afec\u021biuni hepatice sau hipotensiune semnificativ\u0103.<\/p>\n<h3 class=\"wp-block-heading\">C\u00e2t dureaz\u0103 tratamentul?<\/h3>\n<p>Protocolul standard este <strong>21 de zile consecutive<\/strong>, indiferent dac\u0103 apare vasospasmul. Perioada cu cel mai mare risc este zilele 3\u201314, dar tratamentul se extinde p\u00e2n\u0103 la ziua 21 pentru a acoperi evenimente tardive de vasospasm.<\/p>\n<h3 class=\"wp-block-heading\">Nimodip este acela\u0219i lucru cu Nimotop?<\/h3>\n<p>Ambele con\u021bin nimodipin\u0103 30 mg. Nimotop este marca original\u0103 Bayer. Nimodip este un medicament generic bioechivalent la un pre\u021b mai mic.<\/p>\n<div style=\"background:#fff3f3;border-left:4px solid #d9534f;padding:16px 20px;margin:24px 0;border-radius:4px;font-size:13px;\"><strong>Avertizare medical\u0103:<\/strong> Aceast\u0103 pagin\u0103 are scop informativ \u0219i nu \u00eenlocuie\u0219te sfatul medical profesionist. Consulta\u021bi \u00eentotdeauna un furnizor de servicii medicale calificat \u00eenainte de a \u00eencepe, modifica sau \u00eentrerupe orice medica\u021bie. Informa\u021biile privind dozarea reflect\u0103 eticheta produc\u0103torului \u0219i ghidurile clinice publicate \u2014 cerin\u021bele individuale pot diferi.<\/div>\n<p><!-- medsbase-related-alts-v1 --><\/p>\n<h3 class=\"wp-block-heading\">Alternative conexe<\/h3>\n<p>Alte produse din <strong>Afec\u021biuni cronice<\/strong> pe care clien\u021bii le vizualizeaz\u0103 de asemenea:<\/p>\n<ul>\n<li><a href=\"https:\/\/medsbase.com\/ro\/glinil-m\/\">Glinil M<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/trinicalm-plus\/\">Trinicalm Plus<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/opiprol\/\">Opiprol<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/atrest\/\">Atrest<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/ramgee\/\">Ramgee<\/a><\/li>\n<\/ul>","protected":false},"excerpt":{"rendered":"<p>\u2705 Trateaz\u0103 hipertensiunea arterial\u0103<br \/>\n\u2705 Previne accidentul vascular cerebral<br \/>\n\u2705 \u00cembun\u0103t\u0103\u021be\u0219te fluxul sanguin<br \/>\n\u2705 Reduce frecven\u021ba migrenelor<br \/>\n\u2705 Amelioreaz\u0103 problemele cerebrale<\/p>\n<p>Nimodip con\u021bine Nimodipine.<\/p>","protected":false},"featured_media":59457,"comment_status":"open","ping_status":"open","template":"","meta":[],"product_brand":[],"product_cat":[3141,3223,3468],"product_tag":[3892,3893],"class_list":{"0":"post-59456","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_cat-category-overview","7":"product_cat-chronic-conditions","8":"product_cat-neurological-conditions-and-epilepsy","9":"product_tag-nimodip","10":"product_tag-nimodipine","12":"first","13":"instock","14":"shipping-taxable","15":"purchasable","16":"product-type-variable","17":"has-default-attributes"},"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product\/59456","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/comments?post=59456"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/media\/59457"}],"wp:attachment":[{"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/media?parent=59456"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product_brand?post=59456"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product_cat?post=59456"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product_tag?post=59456"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}